Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

Share Price is delayed by 15 minutes
Get Live Data
58.00    1.20 (2.11%)
Bid:
57.80
Ask:
59.20
Spread: 1.40 (2.422%)
Market Cap: £2.33b
OMU Live PriceLast checked at - London Stock Exchange

Intraday Old Mutual Lim. Share Chart

Old Mutual Share Repurchase Programme

3 Oct 2025 12:00

RNS Number : 0286C
Old Mutual Limited
03 October 2025
 

Old Mutual Limited

Incorporated in the Republic of South Africa

 

Registration number: 2017/235138/06

ISIN: ZAE000255360

LEI: 213800MON84ZWWPQCN47

JSE Share Code: OMU

JSE Alpha Code: OMLI

LSE Share Code: OMU

NSX Share Code: OMM

MSE Share Code: OMU

ZSE Share Code: OMU

("Old Mutual" or "Company")

 

Ref: 31/25

 

03 October 2025

 

OLD MUTUAL SHARE REPURCHASE PROGRAMME

 

Shareholders are referred to the General Repurchase Authority granted at the Annual General Meeting held on 30 May 2025, in terms of which shareholders authorised Old Mutual to repurchase up to 10% of its issued ordinary shares in accordance with the Johannesburg Stock Exchange ("JSE") Listings Requirements. The Board has resolved to implement a share repurchase programme ("Repurchase Programme") of approximately 220 million ordinary shares or such number of ordinary shares as may be acquired equivalent to a total consideration of R3 billion. The Repurchase Programme will commence on 03 October 2025 and will continue until the approved authorised limit is reached or for as long as the programme remains value accretive to shareholders.

 

The repurchase of Old Mutual ordinary shares will take place on the JSE only and will be implemented in accordance with the JSE Listing Requirements. The Company has obtained the necessary regulatory approval from the Prudential Authority.

 

The Old Mutual Board and management believe that Old Mutual is trading at a discount to its intrinsic value and is of the view that a Repurchase Programme will deliver longer term incremental value to shareholders. The primary purpose of the Repurchase Programme is to reduce the issued ordinary share capital of the Company.

 

The repurchased ordinary shares shall be cancelled and will revert to authorised but unissued ordinary share capital.

 

This announcement is also available on the Old Mutual website at www.oldmutual.com.

 

Sandton

 

Sponsors

JSE equity sponsor: Tamela Holdings (Proprietary) Limited

JSE debt sponsor: Nedbank Corporate and Investment Banking, a division of Nedbank Limited

NSX: PSG Wealth Management (Namibia) (Proprietary) Limited

ZSE: Imara Capital Zimbabwe plc

MSE: Stockbrokers Malawi Limited

 

Enquiries

Investor Relations

Langa Manqele

M: +27 (0)82 295 9840

E: investorrelations@oldmutual.com

 

Communications

Wendy Tlou

M: +27 (0)82 906 5008

E: oldmutualnews@oldmutual.com

 

About Old Mutual

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key market segments in 12 countries. Old Mutual's primary operations are in Africa and it has a niche business in China. With over 180 years of heritage across sub-Saharan Africa, Old Mutual is a crucial part of the communities it serves as well as broader society on the continent. For further information on Old Mutual and its underlying businesses, please visit the corporate website at www.oldmutual.com.

 

For further information on Old Mutual and its underlying businesses, please visit the corporate website at www.oldmutual.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUOARRVRURRAA
Date   Source Headline
15th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
11th Nov 20221:30 pmRNSForm 8.3 - Mediclinic International plc
4th Nov 20223:10 pmRNSOld Mutual Bula Tsela Transaction
20th Oct 202212:00 pmRNSForm 8.3 - Mediclinic International plc
14th Oct 202211:00 amRNSForm 8.3 - Mediclinic International plc
13th Oct 202212:30 pmRNSForm 8.3 - Mediclinic International plc
12th Oct 20221:00 pmRNSForm 8.3 - Mediclinic International plc
6th Oct 202212:30 pmRNSForm 8.3 - Mediclinic International plc
29th Sep 20221:30 pmRNSForm 8.3 - Mediclinic International plc
29th Sep 20221:00 pmRNSDirectorate Change
23rd Sep 20223:00 pmRNSForm 8.3 - Mediclinic International plc
6th Sep 202210:30 amRNSDirector/PDMR Shareholding
6th Sep 20229:30 amRNSInterim Dividend Currency Equivalents
30th Aug 20227:00 amRNSUnaudited Interim Results and Dividend Declaration
19th Aug 20222:00 pmRNSForm 8.3 - Mediclinic International plc
16th Aug 202212:40 pmRNSForm 8.3 - Mediclinic International plc
12th Aug 20221:30 pmRNSForm 8.3 - Mediclinic International plc
12th Aug 20221:00 pmRNSResults of shareholder voting at GM
11th Aug 20227:00 amRNSTrading Statement
4th Aug 202212:00 pmRNSForm 8.3 - Mediclinic International plc
27th Jul 20222:30 pmRNSForm 8.3 - Mediclinic International plc
26th Jul 20224:00 pmRNSDirectorate Change
26th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
25th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
19th Jul 20222:00 pmRNSForm 8.3 - Mediclinic International plc
18th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Jul 202211:15 amRNSLiving Hands Trust Matter
13th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
13th Jul 202212:00 pmRNSDistribution of circular including notice of GM
7th Jul 20221:30 pmRNSForm 8.3 - Mediclinic International plc
24th Jun 20223:30 pmRNSHolding(s) in Company
23rd Jun 20222:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Jun 20222:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Jun 202211:45 amRNSOMLACSA new financial instrument
20th Jun 20223:00 pmRNSForm 8.3 - Mediclinic International plc
16th Jun 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Jun 20221:00 pmRNSForm 8.3 - Mediclinic International plc
13th Jun 20221:00 pmRNSForm 8.3 - Mediclinic International plc
10th Jun 20224:00 pmRNSForm 8.3 - Mediclinic International plc
6th Jun 20223:45 pmRNSDisposal of Securities by BlackRock. Inc
27th May 202212:15 pmRNSResult of AGM
26th May 202211:00 amRNSOld Mutual Voluntary Operating Update
26th Apr 20222:30 pmRNSNotice of AGM
26th Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Apr 20221:30 pmRNSDealings in Securities
25th Apr 202210:10 amRNSDealings in securities
22nd Apr 20227:00 amRNSRelease of the IR and investor engagement
20th Apr 20222:00 pmRNSOML proposed Bula Tsela B-BBEE transaction
14th Apr 20223:00 pmRNSDealings in Securities on behalf of ESIS
14th Apr 20229:00 amRNSDealings in securities on behalf of ESIS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.